Natural Compounds as Therapeutic Agents: The Case of Human Topoisomerase IB

Natural Compounds as Therapeutic Agents: The Case of Human Topoisomerase IB

Natural products are widely used as source for drugs development. An interesting example is represented by natural drugs developed against human topoisomerase IB, a ubiquitous enzyme involved in many cellular processes where several topological problems occur due the formation of supercoiled DNA. Hu...

Full description

Bibliographic Details
Main Authors:	Alessio Ottaviani, Federico Iacovelli, Paola Fiorani, Alessandro Desideri
Format:	Article
Language:	English
Published:	MDPI AG 2021-04-01
Series:	International Journal of Molecular Sciences
Subjects:	topoisomerase cancer natural products
Online Access:	https://www.mdpi.com/1422-0067/22/8/4138

Similar Items

In Vitro and In Silico Characterization of an Antimalarial Compound with Antitumor Activity Targeting Human DNA Topoisomerase IB
by: Bini Chhetri Soren, et al.
Published: (2021-07-01)

From Antarctica to cancer research: a novel human DNA topoisomerase 1B inhibitor from Antarctic sponge Dendrilla antarctica
by: Alessio Ottaviani, et al.
Published: (2022-12-01)

Dimethylmyricacene: An In Vitro and In Silico Study of a Semisynthetic Non-Camptothecin Derivative Compound, Targeting Human DNA Topoisomerase 1B
by: Alessio Ottaviani, et al.
Published: (2022-11-01)

The antitumor activity of CYB-L10, a human topoisomerase IB catalytic inhibitor
by: Qian Yu, et al.
Published: (2019-01-01)

Phosphorylation of the human topoisomerase II protein
by: Fry, A, et al.
Published: (1992)

Gel-Free Tools for Quick and Simple Screening of Anti-Topoisomerase 1 Compounds
by: Josephine Geertsen Keller, et al.
Published: (2023-04-01)

Plasmodium Topoisomerase VIB and Spo11 Constitute Functional Type IIB Topoisomerase in Malaria Parasite: Its Possible Role in Mitochondrial DNA Segregation
by: Priyanka Singh, et al.
Published: (2023-06-01)

Inhibitory effects of lapachol on rat C6 glioma in vitro and in vivo by targeting DNA topoisomerase I and topoisomerase II
by: Huanli Xu, et al.
Published: (2016-11-01)

Bulge oligonucleotide as an inhibitory agent of bacterial topoisomerase I
by: Zhaoqi Yang, et al.
Published: (2018-01-01)

Actions of a Novel Bacterial Topoisomerase Inhibitor against <i>Neisseria gonorrhoeae</i> Gyrase and Topoisomerase IV: Enhancement of Double-Stranded DNA Breaks
by: Soziema E. Dauda, et al.
Published: (2023-07-01)

Evodiamine Stabilizes Topoisomerase I-DNA Cleavable Complex to Inhibit Topoisomerase I Activity
by: Jau-Lang Hwang, et al.
Published: (2009-03-01)

DNA topoisomerases as molecular targets for anticancer drugs
by: Kamila Buzun, et al.
Published: (2020-01-01)

Design, Synthesis and Cytotoxicity of Thiazole-Based Stilbene Analogs as Novel DNA Topoisomerase IB Inhibitors
by: Jin-Chuan Liu, et al.
Published: (2022-02-01)

SUMO: A Swiss Army Knife for Eukaryotic Topoisomerases
by: Yilun Sun, et al.
Published: (2022-04-01)

Prospects of Topoisomerase Inhibitors as Promising Anti-Cancer Agents
by: Prasanna Anjaneyulu Yakkala, et al.
Published: (2023-10-01)

Dual Targeting Topoisomerase/G-Quadruplex Agents in Cancer Therapy—An Overview
by: Silvia Salerno, et al.
Published: (2022-11-01)

Inhibition of Topoisomerases by Metal Thiosemicarbazone Complexes
by: Xiaohua Jiang, et al.
Published: (2023-07-01)

A Short History of Topoisomerases at Actelion Pharmaceuticals
by: Cornelia Zumbrunn
Published: (2022-08-01)

Neolignans from Licaria chrysophylla and Licaria aurea with DNA topoisomerase II-α inhibitory activity
by: Amanda de Melo Bezerra, et al.
Published: (2012-01-01)

Chili pepper extracts, capsaicin, and dihydrocapsaicin as potential anticancer agents targeting topoisomerases
by: Terézia Hudáková, et al.
Published: (2024-02-01)

What’s on the Other Side of the Gate: A Structural Perspective on DNA Gate Opening of Type IA and IIA DNA Topoisomerases
by: Vita Vidmar, et al.
Published: (2023-02-01)

Type IA Topoisomerases as Targets for Infectious Disease Treatments
by: Ahmed Seddek, et al.
Published: (2021-01-01)

The Potential of Topoisomerase Inhibitor-Based Antibody–Drug Conjugates
by: Seungmin Han, et al.
Published: (2022-08-01)

A Mini Review of Novel Topoisomerase II Inhibitors as Future Anticancer Agents
by: Cosmas O. Okoro, et al.
Published: (2023-01-01)

Role of Topoisomerases in Pediatric High Grade Osteosarcomas: TOP2A Gene Is One of the Unique Molecular Biomarkers of Chemoresponse
by: Natacha Entz-Werle, et al.
Published: (2013-06-01)

Dioxane-Linked Novel Bacterial Topoisomerase Inhibitors Exhibit Bactericidal Activity against Planktonic and Biofilm Staphylococcus aureus In Vitro
by: Anna Chen, et al.
Published: (2022-12-01)

Resveratrol Modulates the Topoisomerase Inhibitory Potential of Doxorubicin in Human Colon Carcinoma Cells
by: Anika Schroeter, et al.
Published: (2014-12-01)

An Improved High Yield Total Synthesis and Cytotoxicity Study of the Marine Alkaloid Neoamphimedine: An ATP-Competitive Inhibitor of Topoisomerase IIα and Potent Anticancer Agent
by: Linfeng Li, et al.
Published: (2014-09-01)

The Implication of Topoisomerase II Inhibitors in Synthetic Lethality for Cancer Therapy
by: Victor M. Matias-Barrios, et al.
Published: (2023-01-01)

Novel Tetrazole-Based Antimicrobial Agents Targeting Clinical Bacteria Strains: Exploring the Inhibition of <i>Staphylococcus aureus</i> DNA Topoisomerase IV and Gyrase
by: Piotr Roszkowski, et al.
Published: (2021-12-01)

Palindromic carbazole derivatives: unveiling their antiproliferative effect via topoisomerase II catalytic inhibition and apoptosis induction
by: Mateusz Olszewski, et al.
Published: (2024-12-01)

Discovery of a novel anticancer agent with both anti-topoisomerase I and II activities in hepatocellular carcinoma SK-Hep-1 cells in vitro and in vivo: Cinnamomum verum component 2-methoxycinnamaldehyde
by: Perng DS, et al.
Published: (2016-01-01)

Phaeophytins from Thyrsacanthus ramosissimus Moric. with inhibitory activity on human dna topoisomerase II-α
by: Analúcia Guedes Silveira Cabral, et al.
Published: (2012-01-01)

Mechanism of Type IA Topoisomerases
by: Tumpa Dasgupta, et al.
Published: (2020-10-01)

Topoisomerase I in Human Disease Pathogenesis and Treatments
by: Min Li, et al.
Published: (2016-06-01)

Archaea: A Gold Mine for Topoisomerase Diversity
by: Florence Garnier, et al.
Published: (2021-05-01)

Developments in Non-Intercalating Bacterial Topoisomerase Inhibitors: Allosteric and ATPase Inhibitors of DNA Gyrase and Topoisomerase IV
by: Scott Grossman, et al.
Published: (2023-02-01)

Effect of etoposide on grass pea DNA topoisomerase II: an in silico, in vivo, and in vitro assessments
by: Aveek Samanta, et al.
Published: (2019-12-01)

Cell-based high-throughput compound screening reveals functional interaction between oncofetal HMGA2 and topoisomerase I
by: Peter, Sabrina, et al.
Published: (2018)

Structural and Biochemical Basis of Etoposide-Resistant Mutations in Topoisomerase IIα
by: Elizabeth G. Gibson, et al.
Published: (2022-06-01)